Literature DB >> 25761830

Breast cancer: a new imaging approach as an addition to existing guidelines.

Monique D Dorrius1, Erik F J de Vries, Riemer H J A Slart, Andor W J M Glaudemans.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25761830     DOI： 10.1007/s00259-015-3032-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  29 in total

1.  Diagnosis of breast cancer: contribution of US as an adjunct to mammography.

Authors:  H M Zonderland; E G Coerkamp; J Hermans; M J van de Vijver; A E van Voorthuisen
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

2.  CMS oncology care model names NCCN guidelines as high-quality care and evidence-based recommendations.

Authors: 
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

3.  Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Authors:  Katja Pinker; Wolfgang Bogner; Pascal Baltzer; Stephan Gruber; Hubert Bickel; Benedikt Brueck; Siegfried Trattnig; Michael Weber; Peter Dubsky; Zsuzsanna Bago-Horvath; Rupert Bartsch; Thomas H Helbich
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

4.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

5.  The negative predictive value of breast Magnetic Resonance Imaging in noncalcified BIRADS 3 lesions.

Authors:  M D Dorrius; R M Pijnappel; P E Sijens; M C Jansen van der Weide; M Oudkerk
Journal:  Eur J Radiol       Date:  2011-01-20       Impact factor: 3.528

6.  Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.

Authors:  Monique D Dorrius; Rudolf M Pijnappel; Marijke C Jansen-van der Weide; Liesbeth Jansen; Peter Kappert; Matthijs Oudkerk; Paul E Sijens
Journal:  Radiology       Date:  2011-04-01       Impact factor: 11.105

7.  Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.

Authors:  S Mahner; S Schirrmacher; W Brenner; L Jenicke; C R Habermann; N Avril; J Dose-Schwarz
Journal:  Ann Oncol       Date:  2008-03-19       Impact factor: 32.976

8.  Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.

Authors:  Carmelo Caldarella; Giorgio Treglia; Alessandro Giordano
Journal:  Clin Breast Cancer       Date:  2013-12-27       Impact factor: 3.225

Review 9.  Molecular imaging of breast cancer.

Authors:  T H Oude Munnink; W B Nagengast; A H Brouwers; C P Schröder; G A Hospers; M N Lub-de Hooge; E van der Wall; P J van Diest; E G E de Vries
Journal:  Breast       Date:  2009-10       Impact factor: 4.380

10.  Positive predictive value of BI-RADS MR imaging.

Authors:  Mary C Mahoney; Constantine Gatsonis; Lucy Hanna; Wendy B DeMartini; Constance Lehman
Journal:  Radiology       Date:  2012-05-15       Impact factor: 11.105
View more
  1 in total

1.  Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT.

Authors:  Wessel McM Vorselaars; Wouter P Kluijfhout; Menno R Vriens; Carmen C van der Pol; Inne Hm Borel Rinkes; Gerlof D Valk; Bart de Keizer
Journal:  Nucl Med Mol Imaging       Date:  2015-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.